This seminar will:
- Provide a primer on the growing role of genetic risk evaluation after diagnosis of cancer
- Discuss the challenges of incorporating genetic risk evaluation and management in patients after diagnosis of cancer and in families at high risk of hereditary cancer syndromes
- Describe two Beau Biden Moonshot cancer clinical trials led by Michigan faculty intended to increase patient and family members access to genetic risk evaluation and management and improve outcomes in the community
The IHPI Research Seminar Series is a lecture-based program designed to share innovative health services research topics, studies, and programs, with clinicians, faculty, research staff, and students from a variety of disciplines.
Following the presentation, stay on to join an informal breakout room from 5:00-5:10 to connect with colleagues.